Get 24/7 website support and maintenance to showcase your antiques dealers or antique shops/warehouses online wherever they are located in Horsham, Petworth, Crawley, West Sussex, East Sussex, Surrey, Hampshire, London, New Zealand, Switzerland. Our web support service can include technical support, website hosting, email hosting, domain name registrations, etc.
Psychosocial recovery services, a vital facet of NDIS offerings, extend a lifeline to individuals grappling with psychosocial disabilities. These services, orchestrated by NDIS disability service providers like Hi-Five, go beyond mere support — they foster empowerment, resilience, and social integration. In this discourse, we delve into the nuances of psychosocial disabilities, elucidate the role of trusted support coordination teams, and underscore the indispensable nature of psychosocial recovery services.
Looking for IT consulting services? Contact SorceTek Technology Group; they help your businesses to improve technology to reach their business goals. Visit their website today!
The following table shows the values that are used when -XX:+UseContainerSupport is set:
Less than 1 GB 50% <size>
1 GB - 2 GB <size> - 512 MB
Greater than 2 GB 75% <size>
The default heap size is capped at 25 GB
The default heap size for containers takes affect only when the following conditions are met:
The application is running in a container environment.
The memory limit for the container is set.
The -XX:+UseContainerSupport option is set, which is the default behavior.
This keynote by Bart Rienties on Oct. 06, 2022 will help you:
-Understand where to start with learning analytics
-Understand how to effectively support your staff to use data
-Critically review whether learning analytics is something for your organisation
Sunday Blake dives into the latest in learning analytics and engagement data, and asks how universities can act upon it to make our interactions with students more human.
21.06.2022 Im Projekt Knight erforscht die Hochschule für Technik Stuttgart den Einsatz von Learning Analytics und künstlicher Intelligenz in der Lehre. Untersucht wird, wie Lernprozesse automatisiert unterstützt werden können, KI in der Lehre verankert werden kann, aber auch wie die Lehrenden von administrativen Aufgaben entlastet werden können.
As part of our mini-series Podcast in AI in Education: Pedagogy first, senior AI specialist Tom Moule speaks with Scott Hayden from Basingstoke College of Technology about they are using AI to support personalised learning.
This episode is all about bias. Our hosts Maren Scheffel and Nia Dowel talk to Shamya Karumbaiah and Rene Kizilcec about bias in learning analytics and some of the work they are doing in that area.
The success of learning analytics rests on how students understand and use them. We asked pre-service teachers how they would see LA supporting their studies in higher education. Learn more about the four roles that we identified from students’ conversations!
The OnTask Project aims to provide personalised, timely support actions to large student cohorts. The two-year project started in 2016 and is funded through a Strategic Priority Commissioned Grant by the Office of Learning and Teaching (OLT) of the Australian Government.
iMooX wurde im Dezember 2013 von der Universität Graz und der Technischen Universität Graz gegründet und ist die erste und einzige österreichische MOOC-Plattform.
This systematic literature review aimed at identifying the pedagogical approaches, aligned with Education 4.0, used to support teaching computer science course with undergraduate and graduate students in Europe.
This thematic series examines the potential and actual impact of artificial intelligence (AI) on higher education (HE). The focus is primarily on the use of AI for supporting teaching and learning.
OU Analyse is a system powered by machine learning methods for early identification of students at risk of failing. All students with their risk of failure in their next assignment are updated weekly and made available to the course tutors and the Student Support Teams to consider appropriate support. The overall objective is to significantly improve the retention of OU students.
This one-day, international symposium aims to unravel some of the mystery around interdisciplinary collaboration and innovation. It builds on the success of the Creativity, Learning, and Technology symposium held in Geneva, December 2017. Participants are local and international experts working within the field. They will share their knowledge regarding recent developments in this exciting area of research and engage in discussions about future directions.
Having dropped out of university because of loneliness and depression, Hayley Mulenda – a former speaker at Jisc’s annual Digifest event - says effective use of data analytics and greater diversity of academic staff are crucial in supporting students.
The first webinar focused on research and case studies relating to the ‘Alert’ stage of supporting students at risk (Alert > Communications > Intervention)
Discover our Messaging Platform for Startups & SMB's. The one stop for sales, marketing & support in one platform : Crisp. 14 Days free trial. No credit-card required. Try now ! We provide Knowledge base, Team Inbox, Chatbot, CRM and multiple other features to let you build your own way to customer success.
Revathi. International Journal of Innovative Research in Information Security, 09 (2):
50-54(мая 2023)1. Muhlenbach, F. and Rakotomalala, R. (2015), “Discretization of Continuous Attributes,” In: Wang, J., Ed., Encyclopedia of Data Warehousing and Mining, Idea Group Reference, 397-402. https://doi.org/10.4018/978-1-59140-557-3.ch076 2. M. Liu, D. Zhang, and D. Shen, “Relationship induced multi- 52 template learning for diagnosis of alzheimer’s disease and mild cognitive impairment,” IEEE transactions on medical imaging, vol. 35, no. 6, p. 1463—1474, (2016). https://doi.org/10.1109/tmi.2016.2515021 3. Abdullah Caliskan, Hasan Badem, A. Baştürk, M.E. Yüksel, “Diagnosis Of The Parkinson Disease By Using Deep Neural Network Classifier”, Journal Of Electrical And Electronics Engineering, (2017):3311-3318 4. M. Abdar and M. Zomorodi-Moghadam, “Impact of Patients’ Gender on Parkinson’s disease using Classification Algorithms” Journal of AI and Data Mining, vol. 6, (2018). 5. Sleigh, J.W.; Olofsen, E.; Dahan, A.; de Goede, J.; Steyn-Ross, A. Entropies of the EEG: The effects of general anaesthesia. In Proceedings of the 5th International Conference on Memory, Awareness and Consciousness, New York, NY, USA, 1–3 June (2019) 6. Tsuda, M., Asano, S., Kato, Y., Murai, K., and Miyazaki, M. (2020). Differential diagnosis of multiple system atrophy with predominant parkinsonism and Parkinson's disease using neural networks. J. Neurol. Sci. 401, 19–26. https://doi.org/10.1016/j.jns.2019.04.014 7. Tysnes, O.-B., and Storstein, A. (2021). Epidemiology of Parkinson's disease. J. Neural Trans. 124, 901–905. https://doi:10.1007/s00702-017-1686-y 8. Parkinson J. An Essay on the Shaking Palsy. London: Sherwood, Neely, and Jones; 1817. pp. 1–16. Google Scholar 9. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson’s disease. Mov Disord. 2003;18:19–31. PubMed Google Scholar 10. National Institute for Health and Care Excellence (NICE) Parkinson’s disease: diagnosis and management in primary and secondary care. NICE clinical guidelines 35. Jun, 2006. Available https://doi.org/10.1136/heartjnl-2022-321095 http://www.nice.org.uk/guidance/cg35/resources/guidance-parkinsons-disease-pdf. Accessed April 28, 2015. 11. Schrag A, Horsfall L, Walters K, et al. Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol. 2015; PubMed Google Scholar https://doi.org/10.1016/s1474-4422(14)70287-x 12. Parkinson’s Disease Foundation Statistics on Parkinson’s. Available at: www.pdf.org.en/parkinson_statistics Accessed June 19, 2014. 13. Driver JA, Logroscino G, Gaziano JM, et al. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009;72:32–38. PMC free article PubMed Google Scholar https://doi.org/10.1212/01.wnl.0000341769.50075.bb 14. De Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–535. PubMed Google Scholar 15. Miller IN, Cronin-Golomb A. Gender differences in Parkinson’s disease: clinical characteristics and cognition. Mov Disord. 2010;25:2695–2703. PMC free article PubMed Google Scholar https://doi.org/10.1002/mds.23388 16. Rumayor MA, Arrieta O, Sotelo J, et al. Female gender but not cigarette smoking delays the onset of Parkinson’s disease. Clin Neurol Neurosurg. 2009;PubMed Google Scholar https://doi.org/10.1016/j.clineuro.2009.07.012 17. Gómez-Esteban JC, Zarranz JJ, Lezcano E, et al. Influence of motor symptoms upon the quality of life of patients with Parkinson’s disease. Eur Neurol. 2007;57:161–165. PubMed Google Scholar https://doi.org/10.1159/000098468 18. Pennington S, Snell K, Lee M, et al. The cause of death in idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:434–437. PubMed Google Scholar https://doi.org/10.1016/j.parkreldis.2010.04.010 19. Jankovic J, Poewe W. Therapies in Parkinson’s disease. Curr Opin Neurol. 2012; PubMed Google Scholar 20. Smith Y, Wichmann T, Factor SA, DeLong MR. Parkinson’s disease therapeutics: new developments and challenges since the introduction of levodopa. Neuropsycho pharmacology. 2012;PMC free article PubMed Google Scholar https://doi.org/10.1038/npp.2011.212 21. Simonson W, Hauser RA, Schapira AHV. Role of the pharmacist in the effective management of wearing-off in Parkinson’s disease. Ann Pharmacother.2007; PubMed Google Scholar https://doi.org/10.1345/aph.1k348 22. Van der Marck MA, Bloem BR, Borm GF, et al. Effectiveness of multidisciplinary care for Parkinson’s disease: a randomized, controlled trial. Mov Disord. 2013;PubMed Google Scholar https://doi.org/10.1002/mds.25194 23. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance. Ann NY Acad Sci. 2008;1147:93–104. PMC free article PubMed Google Scholar https://doi.org/10.1196/annals.1427.023 24. Logroscino G. The role of early-life environmental risk factors in Parkinson disease: what is the evidence? Environ Health Perspect. 2005; PMC free article PubMed Google Scholar https://doi.org/10.1289/ehp.7573 25. Spatola M, Wider C. Genetics of Parkinson’s disease: the yield. Parkinsonism Relat Disord. 2014;20(suppl 1):S35–S38. PubMed Google Scholar https://doi.org/10.1016/s1353-8020(13)70011-7 26. Singleton AB, Farer MJ, Bonifati V. The genetics of Parkinson’s disease: progress and therapeutic implications. Mov Disord. 2013;28:14–23. PMC free article Pu bMed Google Scholar https://doi.org/10.1002/mds.25249 27. Santiago JA, Scherzer CR, Potashkin JA. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson’s disease. PLoS One. 2014; PMC free article PubMed Google Scholar https://doi.org/10.1371/journal.pone.0109042 28. Liu R, Guo X, Park Y, et al. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol. 2012; PMC free article PubMed Google Scholar https://doi.org/10.1093/aje/kwr451 29. Benmoyal-Segal L, Soreq H. Gene–environment interactions in sporadic Parkinson’s disease. J Neurochem. 2006;97:1740–1755. PubMed Google Scholar https://doi.org/10.1111/j.1471-4159.2006.03937.x 30. Van der Merwe C, Haylett W, Harvey J, et al. Factors influencing the development of early- or late-onset Parkinson’s disease in a cohort of South African patients. S Afr Med J. 2012;102:848–851. PubMed Google Scholar https://doi.org/10.7196/samj.5879 31. Wang G, Pan J, Chen SD. Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson’s disease. Prog Neurobiol. 2012; PubMed Google Scholar https://doi.org/10.1016/j.pneurobio.2012.06.003 32. Gilgun-Sherki Y, Djaldetti R, Melamed E, Offen D. Polymorphism in candidate genes: implications for the risk and treatment of idiopathic Parkinson’s disease. Pharmacogenomics J. 2004;4:291–306. PubMed Google Scholar https://doi.org/10.1038/sj.tpj.6500260 33. Agúndez JA, García-Martín E, Alonso-Navarro H, et al. Anti-Parkinson’s disease drugs and pharmacogenetic considerations. Expert Opin Drug Metab Toxicol. 2013;9:859–874. PubMed Google Scholar https://doi.org/10.1517/17425255.2013.789018 34. Marras C, Goldman SM. Genetics meets environment: evaluating gene–environment interactions in neurologic diseases. Semin Neurol. 2011;31:553–561. PubMed Google Scholar https://doi.org/10.1055/s-0031-1299793 35. Soreq L, Ben-Shaul Y, Israel Z, et al. Meta-analysis of genetic and environmental Parkinson’s disease models reveals a common role of mitochondrial protection pathways. Neurobiol Dis. 2012;45:1018–1030. PubMed Google Scholar https://doi.org/10.1016/j.nbd.2011.12.021 36. Curtin K, Fleckenstein AE, Robison RJ, et al. Methamphetamine/amphetamine abuse and risk of Parkinson’s disease in Utah: a population-based assessment. Drug Alcohol Depend. 2015;146:30–38. PMC free article PubMed Google Scholar https://doi.org/10.1016/j.drugalcdep.2014.10.027 37. Chen JJ, Swope DM. Parkinson’s disease. In: DiPiro JT, Talbert RL, Yee GC, et al., editors. Pharmacotherapy: A Pathophysiologic Approach. 9th ed. New York, New York: McGraw-Hill; 2014. Google Scholar 38. Chade AR, Kasten M, Tanner CM. Nongenetic causes of Parkinson’s disease. J Neural Transm Suppl. 2006;70:147–151. PubMed Google Scholar https://doi.org/10.1007/978-3-211-45295-0_23.
N. Rzepka, K. Simbeck, H. Müller, и N. Pinkwart. Proceedings of the 14th International Conference on Computer Supported Education, SCITEPRESS - Science and Technology Publications, (2022)